SCHEMBL23728512

SCHEMBL23728512

CNC1CCN(c2cccc3c2n(C)c(=O)n3C2C(=O)CCNC2=O)CC1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
DRD2 P14416 2/20 0.31
DRD3 P35462 2/20 0.31
ROCK2 O75116 1/20 0.30
ROCK1 Q13464 1/20 0.30
CDC42BPB Q9Y5S2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23536287 0.87 ADRB1 (0.36) DRD2DRD3
SCHEMBL25340231 0.85
SCHEMBL27224961 0.84 ENPP1 (0.33) DDB1CRBNDRD2DRD3
SCHEMBL25340885 0.84 DDB1 (0.31) DDB1CRBN
SCHEMBL23536575 0.82 DRD2 (0.42) DDB1CRBNDRD2
SCHEMBL23536286 0.82 DRD2 (0.33) DDB1CRBNDRD2
SCHEMBL22835213 0.79 DDB1 (0.57) DDB1CRBN
Hydrochloric Acid SCHEMBL30393221 0.78 DDB1 (0.56) DDB1CRBN
SCHEMBL22835167 0.78 DDB1 (0.33) DDB1CRBN
SCHEMBL25931519 0.78 DDB1 (0.45) DDB1CRBNDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100004-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2022-12-14 EP disclosed
WO-2021158634-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-08-12 WO disclosed